Read more
4:19 PM · 5 February 2024

MorphoSys gains 37% amid rumours of possible takeover by Novartis

-
-
Open account Download free app

Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.

The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.

MorphoSys shares are currently gaining nearly 37%.

Source: xStation

22 January 2026, 3:59 PM

Meta Platforms shares surge amid Jefferies 'Buy' recommendation 📈

22 January 2026, 3:36 PM

US Open: Rebound attempt on Wall Street 📈Meta Platforms surges 3.5%

22 January 2026, 2:24 PM

Stock of the Week: TSMC, the heart of the global AI revolution (January 22, 2026)

22 January 2026, 11:30 AM

Intel Q4 2025: Quarterly Results Will Show If the Strategy Works 📊

Join over 2 000 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits